Clinical Trial Update: Dose Study of ACAM2000 Smallpox Vaccine in Previously Vaccinated Adults [Phase 2]

View source ↗

Summary

Phase 2 dose study of ACAM2000 smallpox vaccine in adults previously vaccinated, with completed results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smallpox

Drugs mentioned

• ACAM2000 (Vaccinia vaccine (live, cell culture-derived))

Snippet

Sponsor: Emergent BioSolutions | Conditions: Smallpox | Phase 2 | Status: COMPLETED | Results posted: 2011-02-11